Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 125 results.
User Information
Export Records
  1. 1.   Genomes and epigenomes of matched normal and tumor breast tissue reveal diverse evolutionary trajectories and tumor-host interactions
  2. Zhu, Bin; Tapinos, Avraam; Koka, Hela; Yi Lee, Priscilla Ming; Zhang, Tongwu; Zhu, Wei; Wang, Xiaoyu; Klein, Alyssa; Lee, DongHyuk; Tse, Gary M; Tsang, Koon-Ho; Wu, Cherry; Hua, Min; Highfill,Chad; Lenz,Petra; Zhou,Weiyin; Wang,Difei; Luo,Wen; Jones,Kristine; Hutchinson,Amy; Hicks,Belynda; Garcia-Closas, Montserrat; Chanock, Stephen; Tse, Lap Ah; Wedge, David C; Yang, Xiaohong R
  3. American Journal of Human Genetics. 2024, Oct 29;
  1. 2.   Adjuvant COX inhibition augments STING signaling and cytolytic T cell infiltration in irradiated 4T1 tumors
  2. Ridnour,Lisa; Cheng,Robert; Kedei, Noemi; Somasundaram, Veena; Bhattacharyya, Dibyangana D; Basudhar, Debashree; Wink, Adelaide L; Walke, Abigail J; Kim,Caleb; Heinz,Will; Edmondson,Elijah; Butcher,Donna; Warner,Andrew; Dorsey, Tiffany H; Pore, Milind; Kinders, Robert J; Lipkowitz, Stanley; Bryant, Richard J; Rittscher, Jens; Wong, Stephen Tc; Hewitt, Stephen M; Chang, Jenny C; Shalaby, Aliaa; Callagy, Grace M; Glynn, Sharon A; Ambs, Stefan; Anderson,Steve; McVicar,Dan; Lockett,Stephen; Wink,David
  3. JCI Insight. 2024, May 21; 9(12):
  1. 3.   Germline pathogenic variants associated with triple-negative breast cancer in US Hispanic and Guatemalan women using hospital and community-based recruitment strategies
  2. Godinez Paredes, Jesica M; Rodriguez, Isabel; Ren, Megan; Orozco, Anali; Ortiz, Jeremy; Albanez, Anaseidy; Jones, Catherine; Nahleh, Zeina; Barreda, Lilian; Garland,Lisa; Torres-Gonzalez, Edmundo; Wu,Dongjing; Luo,Wen; Liu,Jia; Argueta, Victor; Orozco, Roberto; Gharzouzi, Eduardo; Dean, Michael
  3. Breast Cancer Research and Treatment. 2024, Mar 23;
  1. 4.   Metabolism-focused CRISPR screen unveils mitochondrial pyruvate carrier 1 as a critical driver for PARP inhibitor resistance in lung cancer
  2. Furusawa, Takashi; Cavero, Renzo; Liu, Yue; Li, Haojian; Xu,Xia; Andresson,Thorkell; Reinhold, William; White, Olivia; Boufraqech, Myriem; Meyer,Thomas; Hartmann, Oliver; Diefenbacher, Markus E; Pommier, Yves; Weyemi, Urbain
  3. Molecular Carcinogenesis. 2024, Feb 27;
  1. 5.   Distinct uptake and elimination profiles for trastuzumab, human IgG and biocytin-TMR in experimental HER2+ brain metastases of breast cancer
  2. Silvestri, Vanesa L; Tran, Andy D; Chung, Monika; Chung, Natalie; Gril, Brunilde; Robinson,Christina; Difilippantonio,Simone; Wei, Debbie; Kruhlak, Michael J; Peer, Cody J; Figg, W Douglas; Khan, Imran; Steeg, Patricia S
  3. Neuro-Oncology. 2024, Feb 13;
  1. 6.   Mismatch repair protein MLH1 suppresses replicative stress in BRCA2 deficient breast tumors
  2. Sengodan,Satheesh; Hu, Xiaoju; Peddibhotla, Vaishnavi; Balamurugan, Kuppusamy; Mitrophanov,Alex; McKennett,Lois; Kharat, Suhas S; Sanawar, Rahul; Singh, Vinod Kumar; Albaugh,Mary; Burkett,Sandra; Zhao,Yongmei; Tran,Bao; Malys,Tyler; Sterneck,Esta; De, Subhajyoti; Sharan,Shyam
  3. The Journal of Clinical Investigation. 2024, Jan 25; 134(7):
  1. 7.   Engineering CD276/B7-H3-targeted antibody-drug conjugates with enhanced cancer-eradicating capability
  2. Feng,Yang; Lee,Jaewon; Yang,Liping; Hilton,Mary; Morris,Karen; Seaman,Steven; Edupuganti,Shivaji; Hsu,Kuo-Sheng; Dower, Christopher; Yu,Guojun; So,Daeho; Bajgain,Pradip; Zhu, Zhongyu; Dimitrov, Dimiter S; Patel,Nimit; Robinson,Christina; Difilippantonio,Simone; Dyba,Marzena; Corbel,Amanda; Basuli, Falguni; Swenson, Rolf E; Kalen,Joseph; Suthe, Sreedhar Reddy; Hussain, Myer; Italia, James S; Souders, Colby A; Gao, Ling; Schnermann,Martin; St Croix,Brad
  3. Cell Reports. 2023, Nov 28; 42(12): 113503.
  1. 8.   Sequencing-based functional assays for classification of BRCA2 variants in mouse ESCs
  2. Biswas,Kajal; Mitrophanov,Alex; Sahu,Sounak; Sullivan,Teresa; Southon,Eileen; Nousome,Darryl; Reid, Susan; Narula, Sakshi; Smolen, Julia; Sengupta, Trisha; Riedel-Topper, Maximilian; Kapoor, Medha; Babbar, Anav; Stauffer,Stacey; Cleveland, Linda; Tandon, Mayank; Malys,Tyler; Sharan,Shyam
  3. Cell Reports Methods. 2023, Nov 20; 3(11): 100628.
  1. 9.   Host, reproductive, and lifestyle factors in relation to quantitative histologic metrics of the normal breast
  2. Abubakar, Mustapha; Klein, Alyssa; Fan, Shaoqi; Lawrence,Scott; Mutreja,Karun; Henry, Jill E; Pfeiffer, Ruth M; Duggan, Maire A; Gierach, Gretchen L
  3. Breast Cancer Research : BCR. 2023, Aug 15; 25(1): 97.
  1. 10.   A Single-Arm, Open-Label Phase II Study of ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma
  2. Atkins, Sarah L P; Greer, Yoshimi Endo; Jenkins, Sarah; Gatti-Mays, Margaret E; Houston, Nicole; Lee, Sunmin; Lee, Min-Jung; Rastogi, Shraddha; Sato, Nahoko; Burks,Christina; Annunziata, Christina M; Lee, Jung-Min; Nagashima, Kunio; Trepel, Jane B; Lipkowitz, Stanley; Zimmer, Alexandra S
  3. The Oncologist. 2023, Jun 05;
  1. 11.   Tumor eradication by hetIL-15 locoregional therapy correlates with an induced intratumoral CD103intCD11b+ dendritic cell population
  2. Stellas, Dimitris; Karaliota,Sevasti; Stravokefalou, Vasiliki; Angel, Matthew; Nagy,Bethany; Goldfarbmuren,Kate; Bergamaschi, Cristina; Felber,Barbara; Pavlakis,George
  3. Cell Reports. 2023, May 12; 42(5): 112501.
  1. 12.   DNA methylation age in paired tumor and adjacent normal breast tissue in Chinese women with breast cancer
  2. Koka, Hela; Bodelon, Clara; Horvath, Steve; Lee, Priscilla Ming Yi; Wang,Difei; Song,Lei; Zhang, Tongwu; Hurson, Amber N; Guida, Jennifer Lyn; Zhu, Bin; Bailey-Whyte, Maeve; Wang, Feng; Wu, Cherry; Tsang, Koon Ho; Tsoi, Yee-Kei; Chan, W C; Law, Sze Hong; Hung, Ray Ka Wai; Tse, Gary M; Yuen, Karen Ka-Wan; Karlins, Eric; Jones,Kristine; Vogt,Aurelie; Zhu, Bin; Hutchinson,Amy; Hicks,Belynda; Garcia-Closas, Montserrat; Chanock, Stephen; Barnholtz-Sloan, Jill; Tse, Lap Ah; Yang, Xiaohong R
  3. Clinical Epigenetics. 2023, Mar 30; 15(1): 55.
  1. 13.   Stabilization of E-cadherin adhesions by COX-2/GSK3ß signaling is a targetable pathway in metastatic breast cancer
  2. Balamurugan, Kuppusamy; Poria, Dipak K; Sehareen, Saadiya W; Krishnamurthy, Savitri; Tang, Wei; McKennett,Lois; Padmanaban, Veena; Czarra,Kelli; Ewald, Andrew J; Ueno, Naoto T; Ambs, Stefan; Sharan, Shikha; Sterneck,Esta
  3. JCI Insight. 2023, Feb 09; 8(6):
  1. 14.   Chronic Exposure to Nitric Oxide Induces P53 Mutations and Malignant-like Features in Human Breast Epithelial Cells
  2. Cheng,Robert; Burkett,Sandra; Ambs, Stefan; Moody, Terry; Wink,David; Ridnour,Lisa
  3. Biomolecules. 2023, Feb 07; 13(2):
  1. 15.   Loss of Brca1 and Trp53 in adult mouse mammary ductal epithelium results in development of hormone receptor-positive or hormone receptor-negative tumors, depending on inactivation of Rb family proteins
  2. Szabova,Ludmila; Gordon, Melanie B; Lu, Lucy; Pate, Nathan; Bassel,Laura; Iacovelli, Anthony J; Karim,Baktiar; Homan, Philip J; Householder,Deborah; Guerin,Theresa; Burkett,Sandra; Day,Amanda; Custer Lawrence,Wendi; Ohler,Zoe
  3. Breast Cancer Research : BCR. 2022, Nov 04; 24(1): 75.
  1. 16.   Metastasis suppressor NME1 in exosomes or liposomes conveys motility and migration inhibition in breast cancer model systems
  2. Khan, Imran; Gril, Brunilde; Hoshino, Ayuko; Yang, Howard H; Lee, Maxwell P; Difilippantonio,Simone; Lyden, David C; Steeg, Patricia S
  3. Clinical & Experimental Metastasis. 2022, Aug 08;
  1. 17.   Aminoflavone upregulates putative tumor suppressor miR-125b-2-3p to inhibit luminal A breast cancer stem cell-like properties
  2. Mavingire, Nicole; Campbell,Petreena; Liu, Tiantian; Wooten, Jonathan; Khan, Salma; Chen, Xin; Matthews, Jason; Wang, Charles; Brantley, Eileen
  3. Precision Clinical Medicine. 2022, Jun; 5(2): pbac008.
  1. 18.   Protein expression of the gp78 E3-ligase predicts poor breast cancer outcome based on race
  2. Singhal, Sandeep K; Byun, Jung S; Yan, Tingfen; Yancey, Ryan; Caban, Ambar; Gil Hernandez, Sara; Bufford, Sediqua; Hewitt, Stephen M; Winfield, Joy; Pradhan, Jaya Sarin; Mustkov, Vesco; McDonald, Jasmine A; Pérez-Stable, Eliseo J; Napoles, Anna Maria; Vohra, Nasreen; De Siervi, Adriana; Yates, Clayton; Davis, Melissa B; Yang,Mei; Tsai,Yien Che; Weissman,Allan; Gardner, Kevin
  3. JCI Insight. 2022, May 31;
  1. 19.   Metabolic Profile, Biotransformation, Docking Studies and Molecular Dynamics Simulations of Bioactive Compounds Secreted by CG3 Strain
  2. Messaoudi, Omar; Sudarman, Enge; Patel,Chiragkumar; Bendahou, Mourad; Wink, Joachim
  3. Antibiotics (Basel, Switzerland). 2022, May 13; 11(5):
  1. 20.   A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer
  2. Manzo, Julia; Puhalla, Shannon; Pahuja, Shalu; Ding, Fei; Lin, Yan; Appleman, Leonard; Tawbi, Hussein; Stoller, Ronald; Lee, James J; Diergaarde, Brenda; Kiesel, Brian F; Yu, Jing; Tan, Antoinette R; Belani, Chandra P; Chew, Helen; Garcia, Agustin A; Morgan, Robert J; Wahner Hendrickson, Andrea E; Visscher, Daniel W; Hurley, Rachel M; Kaufmann, Scott H; Swisher, Elizabeth M; Oesterreich, Steffi; Katz, Tiffany; Ji,Jay; Zhang, Yiping; Parchment, Ralph E; Chen, Alice; Duan, Wenrui; Giranda, Vincent; Shepherd, Stacie P; Ivy, S Percy; Chu, Edward; Beumer, Jan H
  3. Cancer Chemotherapy and Pharmacology. 2022, Apr 18; 89(5): 721-735.
  1. 21.   Heterodimeric IL-15 (hetIL-15) reduces circulating tumor cells and metastasis formation improving chemotherapy and surgery in 4T1 mouse model of TNBC
  2. Stravokefalou, Vasiliki; Stellas, Dimitris; Karaliota,Sevasti; Nagy,Bethany; Valentin, Antonio; Bergamaschi, Cristina; Dimas, Konstantinos; Pavlakis,George
  3. Frontiers in Immunology. 2022, Jan 13; 13: 1014802.
  1. 22.   Comparison of somatic mutation landscapes in Chinese versus European breast cancer patients
  2. Zhu, Bin; Joo, Lijin; Zhang, Tongwu; Koka, Hela; Lee, DongHyuk; Shi, Jianxin; Lee, Priscilla; Wang, Difei; Wang, Feng; Chan, Wing-Cheong; Law, Sze Hong; Tsoi, Yee-Kei; Tse, Gary M; Lai, Shui Wun; Wu, Cherry; Yang, Shuyuan; Yang Chan, Emily Ying; Shan Wong, Samuel Yeung; Wang, Mingyi; Song, Lei; Jones, Kristine; Zhu, Bin; Hutchinson, Amy; Hicks, Belynda; Prokunina-Olsson, Ludmila; Garcia-Closas, Montserrat; Chanock, Stephen; Tse, Lap Ah; Yang, Xiaohong R
  3. HGG Advances. 2021, Dec 3; 3(1): 100076.
  1. 23.   Yuanhuacine Is a Potent and Selective Inhibitor of the Basal-Like 2 Subtype of Triple Negative Breast Cancer with Immunogenic Potential
  2. Fermaintt, Charles S.; Peramuna, Thilini; Cai, Shengxin; Takahashi-Ruiz, Leila; Essif, Jacob Nathaniel; Grant, Corena V.; O'Keefe,Barry; Mooberry, Susan L.; Cichewicz, Robert H.; Risinger, April L.
  3. Cancers. 2021, JUN; 13(11):
  1. 24.   Cancer stem cells: Culprits in endocrine resistance and racial disparities in breast cancer outcomes
  2. Mavingire, Nicole; Campbell,Petreena; Wooten, Jonathan; Aja, Joyce; Davis, Melissa B.; Loaiza-Perez, Andrea; Brantley, Eileen
  3. CANCER LETTERS. 2021, Mar 1; 500: 64-74.
  1. 25.   Epidemiological and ES cell-based Functional Evaluation of BRCA2 Variants Identified in Families with Breast Cancer
  2. O'Sullivan,Theresa; Thirthagiri, Eswary; Chong, Chan-Eng; Stauffer,Stacey; Reid,Susan; Southon,Eileen; Hassan, Tiara; Ravichandran, Aravind; Wijaya, Eldarina; Lim, Joanna; Taib, Nur Aishah Mohd; Fadzli, Farhana; Yip, Cheng Har; Hartman, Mikael; Li, Jingmei; van Dam, Rob M; North, Susan L; Das, Ranabir; Easton, Douglas F; Biswas,Kajal; Teo, Soo-Hwang; Sharan,Shyam
  3. Human Mutation. 2021, Feb; 42(2): 200-212.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel